Growth Metrics

Agilon Health (AGL) Gains from Sales and Divestitures (2022)

Agilon Health posted quarterly Gains from Sales and Divestitures of $404000.0 for Q4 2022.

Agilon Health (AGL) has 1 years of Gains from Sales and Divestitures data on file, last reported at $404000.0 in Q4 2022.

  • For the quarter ending Q4 2022, Gains from Sales and Divestitures changed N/A year-over-year to $404000.0; the trailing twelve-month figure through Dec 2022 stood at $404000.0 (changed N/A YoY), and the FY2022 full-year result was $404000.0, changed N/A from the prior year.
  • Gains from Sales and Divestitures for Q4 2022 stood at $404000.0.
  • Across five years, Gains from Sales and Divestitures topped out at $404000.0 in Q4 2022 and bottomed at $404000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 Agilon Health 1.53 Bn 1.30 Bn 1.05 Bn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 404,000.00
Dec 31, 2022 404,000.00